Impact of Candida spp. isolation in the respiratory tract in patients with intensive care unit-acquired pneumonia

Clinical Microbiology and Infection

Volumn 22, Issue 1, 2016, Pages 94.e1-94.e8

  Terraneo, S ^a,b   Ferrer, M ^a,c   Martin Loeches I ^d   Esperatti, M ^a   Di Pasquale, M ^a,b   Giunta, V ^a   Rinaudo, M ^a   de Rosa, F ^a,b   Li Bassi, G ^a,c   Centanni, S ^b   Torres, A ^a,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF MILAN   (Italy)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d ST JAMES S HOSPITAL   (Ireland)

Author keywords

Candida isolation; Intensive care unit acquired pneumonia; Nosocomial infection; Systemic inflammatory response; Ventilator associated pneumonia

Indexed keywords

ADRENOMEDULLIN; AMPHOTERICIN B; ANIDULAFUNGIN; C REACTIVE PROTEIN; CASPOFUNGIN; FLUCONAZOLE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; ITRACONAZOLE; PROADRENOMEDULLIN; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA; VORICONAZOLE;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; CANDIDA; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY ASSESSMENT; FEMALE; FUNGUS ISOLATION; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; IMMUNOCOMPETENCE; INFECTION RISK; INFLAMMATION; INTENSIVE CARE UNIT; INTENSIVE CARE UNIT ACQUIRED PNEUMONIA; LOWER RESPIRATORY TRACT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PATIENT HISTORY OF SURGERY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY CANDIDIASIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; SURVIVAL TIME; CROSS INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOLOGY; PNEUMONIA; RESPIRATORY SYSTEM; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

CANDIDA; CROSS INFECTION; HUMANS; INTENSIVE CARE UNITS; PNEUMONIA; PROSPECTIVE STUDIES; RESPIRATORY SYSTEM; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 85016925226     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.09.002     Document Type: Article

References (43)

1. American Thoracic Society Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and Healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416.
2. Esperatti M., Ferrer M., Theessen A., Liapikou A., Valencia M., Saucedo L.M., et al. Nosocomial pneumonia in the intensive care unit acquired during mechanical ventilation or not. Am J Respir Crit Care Med 2010, 182:1533-1539.
3. Koulenti D., Lisboa T., Brun-Buisson C., Krueger W., Macor A., Sole-Violan J., et al. Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit Care Med 2009, 37:2360-2368.
4. Baum G.L. The significance of Candida albicans in human sputum. N Engl J Med 1960, 263:70-73.
5. Morales D.K., Hogan D.A. Candida albicans interactions with bacteria in the context of human health and disease. PLoS Pathog 2010, 6:e1000886.
6. Pittet D., Monod M., Suter P.M., Frenk E., Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994, 220:751-758.
7. El-Ebiary M., Torres A., Fàbregas N., Puig de la Bellacasa J., González J., Ramirez J., et al. Significance of the Isolation of Candida species from respiratory samples in critically-ill, non-neutropenic patients: an immediate postmortem histologic study. Am J Respir Crit Care Med 1997, 156:583-590.
8. Meersseman W., Lagrou K., Spriet I., Maertens J., Verbeken E., Peetermans W.E., et al. Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study. Intensive Care Med 2009, 35:1526-1531.
9. Rello J., Esandi M.E., Diaz E., Mariscal D., Gallego M., Vallés J. The role of candida sp isolated from bronchoscopic samples in neutropenic patients. Chest 1998, 114:146-149.
10. Delisle M.S., Williamson D.R., Albert M., Perreault M.M., Jiang X., Day A.G., et al. Impact of Candida species on clinical outcomes in patients with suspected ventilator-associated pneumonia. Can Respir J 2011, 18:131-136.
11. Williamson D.R., Albert M., Perreault M.M., Delisle M.S., Muscedere J., Rotstein C., et al. The relationship between Candida species cultured from the respiratory tract and systemic inflammation in critically ill patients with ventilator-associated pneumonia. Can J Anaesth 2011, 58:275-284.
12. Hamet M., Pavon A., Dalle F., Pechinot A., Prin S., Quenot J.P., et al. Candida spp. airway colonization could promote antibiotic-resistant bacteria selection in patients with suspected ventilator-associated pneumonia. Intensive Care Med 2012, 38:1272-1279.
13. Azoulay E., Timsit J.F., Tafflet M., de L.A., Darmon M., Zahar J.R., et al. Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia. Chest 2006, 129:110-117.
14. Kohlenberg A., Schwab F., Behnke M., Geffers C., Gastmeier P. Pneumonia associated with invasive and noninvasive ventilation: an analysis of the German nosocomial infection surveillance system database. Intensive Care Med 2010, 36:971-978.
15. Karhu J., la-Kokko T.I., Ylipalosaari P., Ohtonen P., Laurila J.J., Syrjala H. Hospital and long-term outcomes of ICU-treated severe community- and hospital-acquired, and ventilator-associated pneumonia patients. Acta Anaesthesiol Scand 2011, 55:1254-1260.
16. Fabregas N., Ewig S., Torres A., El Ebiary M., Ramirez J., de la Bellacasa J.P., et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 1999, 54:867-873.
17. Woodhead M.A., Torres A. Definition and classification of community-acquired and nosocomial pneumonias. Pneumonia 1997, 1-12. European Respiratory Society Journals Ltd., Sheffield, UK. A. Torres, M. Woodhead (Eds.).
18. Giunta V., Ferrer M., Esperatti M., Ranzani O.T., Saucedo L.M., Bassi G.L., et al. ICU-acquired pneumonia with or without etiologic diagnosis: a comparison of outcomes. Crit Care Med 2013, 41:2133-2143.
19. Di Pasquale M., Ferrer M., Esperatti M., Crisafulli E., Giunta V., Bassi G.L., et al. Assessment of severity of ICU-acquired pneumonia and association with etiology. Crit Care Med 2014, 42:303-312.
20. Ruiz M., Torres A., Ewig S., Marcos M.A., Alcón A., Lledó R., et al. Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome. Am J Respir Crit Care Med 2000, 162:119-125.
21. Murray P.R., Baron E.J., Joergensen J.H., Pfaller M.A., Yolken R.H. Manual of clinical microbiology 2003, American Society for Microbiology, Washington DC. 8th ed.
22. Le Gall J.R., Lemeshow S., Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963.
23. Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonca A., Bruining H., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710.
24. Luna C.M., Blanzaco D., Niederman M.S., Matarucco W., Baredes N.C., Desmery P., et al. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 2003, 31:676-682.
25. Dellinger R.P., Levy M.M., Carlet J.M., Bion J., Parker M.M., Jaeschke R., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327.
26. Ranieri V.M., Rubenfeld G.D., Thompson B.T., Ferguson N.D., Caldwell E., Fan E., et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012, 307:2526-2533.
27. Ioanas M., Ferrer M., Cavalcanti M., Ferrer R., Ewig S., Filella X., et al. Causes and predictors of non-response to treatment of the ICU-acquired pneumonia. Crit Care Med 2004, 32:938-945.
28. Esperatti M., Ferrer M., Giunta V., Ranzani O.T., Saucedo L.M., Li B.G., et al. Validation of predictors of adverse outcomes in hospital-acquired pneumonia in the ICU. Crit Care Med 2013, 41:2151-2161.
29. Barriere S.L. Challenges in the design and conduct of clinical trials for hospital-acquired pneumonia and ventilator-associated pneumonia: an industry perspective. Clin Infect Dis 2010, 51(Suppl 1):S4-S9.
30. Ramirez P., Ferrer M., Marti V., Reyes S., Martinez R., Menendez R., et al. Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia. Crit Care Med 2011, 39:2211-2217.
31. Bello S., Lasierra A.B., Minchole E., Fandos S., Ruiz M.A., Vera E., et al. Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology. Eur Respir J 2012, 39:1144-1155.
32. Hosmer D., Lemeshow S. Applied logistic regression 1989, Wiley, New York.
33. Wood G.C., Mueller E.W., Croce M.A., Boucher B.A., Fabian T.C. Candida sp. isolated from bronchoalveolar lavage: clinical significance in critically ill trauma patients. Intensive Care Med 2006, 32:599-603.
34. Chastre J., Fagon J.Y. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002, 165:867-903.
35. Delisle M.S., Williamson D.R., Perreault M.M., Albert M., Jiang X., Heyland D.K. The clinical significance of Candida colonization of respiratory tract secretions in critically ill patients. J Crit Care 2008, 23:11-17.
36. Fagon J.Y., Lavarde V., Novara A., Mathieu G., Stephan F., Buu Hoi A., et al. Nosocomial Candida infections of the lower respiratory tract (LRT) in ICU patients. Am J Respir Crit Care Med 1994, 149:A650.
37. Pallavan B., Ramesh V., Dhanasekaran B.P., Oza N., Indu S., Govindarajan V. Comparison and correlation of candidal colonization in diabetic patients and normal individuals. J Diabetes Metab Disord 2014, 13:66.
38. Mojazi Amiri H., Frandah W., Colmer-Hamood J., Raj R., Nugent K. Risk factors of Candida colonization in the oropharynx of patients admitted to an intensive care unit. J Mycol Med 2012, 22:301-307.
39. Roux D., Gaudry S., Dreyfuss D., El-Benna J., de P.N., Denamur E., et al. Candida albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat. Crit Care Med 2009, 37:1062-1067.
40. Ader F., Jawhara S., Nseir S., Kipnis E., Faure K., Vuotto F., et al. Short term Candida albicans colonization reduces Pseudomonas aeruginosa-related lung injury and bacterial burden in a murine model. Crit Care 2011, 15:R150.
41. Garnacho-Montero J., Olaechea P., varez-Lerma F., varez-Rocha L., Blanquer J., Galvan B., et al. Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient. Rev Esp Quimioter 2013, 26:173-188.
42. Nseir S., Jozefowicz E., Cavestri B., Sendid B., Di P.C., Dewavrin F., et al. Impact of antifungal treatment on Candida-Pseudomonas interaction: a preliminary retrospective case-control study. Intensive Care Med 2007, 33:137-142.
43. Azoulay E., Cohen Y., Zahar J.R., Garrouste-Orgeas M., Adrie C., Moine P., et al. Practices in non-neutropenic ICU patients with Candida-positive airway specimens. Intensive Care Med 2004, 30:1384-1389.